BCAX Bicara Therapeutics Inc.
Nasdaq · SEC CIK 2023658 · EDGAR
- Bought, last 12 months
- $4.80M 1 purchases by 1 insiders
- Sold, last 12 months
- $13.54M 41 sales by 5 insiders
- Filings on record
- 84 since 2024-09-16, latest 2026-09-10 16:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $4.80M | — |
| Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | — | $4.60M |
| Mazumdar Claire | CEO, Dir | — | $4.06M |
| Hyep Ivan | CFO | — | $3.24M |
| Raben David | Chief Medical Off | — | $1.15M |
| Meisner Lara | CLO | — | $498.7K |
Transactions 99
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-10 16:23 | 2026-09-08 | BCAX | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | M - OptEx | $3.79 | +17.5K | 199.1K | +10% | +$66.3K |
| DMT | 2026-09-10 16:23 | 2026-09-08 | BCAX | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | S - Sale+OE | $22.90 | -17.5K | 181.6K | -9% | -$400.7K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +12.5K | 142.4K | +10% | +$47.4K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $27.97 | -12.5K | 129.9K | -9% | -$349.6K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +10.0K | 372.2K | +3% | +$37.9K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $27.98 | -10.0K | 362.2K | -3% | -$279.8K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +18.8K | 200.4K | +10% | +$71.1K |
| DT | 2026-08-12 16:19 | 2026-08-10 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $27.98 | -18.8K | 181.6K | -9% | -$524.5K |
| DT | 2026-07-14 16:22 | 2026-07-10 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +10.0K | 372.2K | +3% | +$37.9K |
| DMT | 2026-07-14 16:22 | 2026-07-10 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $28.42 | -10.0K | 362.2K | -3% | -$284.2K |
| DT | 2026-07-10 16:10 | 2026-07-08 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +18.8K | 210.4K | +10% | +$71.1K |
| DMT | 2026-07-10 16:10 | 2026-07-08+ | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $28.98 | -28.8K | 181.6K | -14% | -$833.1K |
| DT | 2026-07-10 16:10 | 2026-07-08 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +12.5K | 157.9K | +9% | +$47.4K |
| DMT | 2026-07-10 16:10 | 2026-07-08 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $28.85 | -28.0K | 129.9K | -18% | -$807.7K |
| DT | 2026-05-26 17:48 | 2026-05-21 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +9,200 | 154.6K | +6% | +$34.9K |
| DT | 2026-05-26 17:48 | 2026-05-21 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $20.42 | -9,200 | 145.4K | -6% | -$187.9K |
| DT | 2026-05-20 16:07 | 2026-05-18 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +15.0K | 377.2K | +4% | +$56.8K |
| DMT | 2026-05-20 16:07 | 2026-05-18 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $20.04 | -15.0K | 362.2K | -4% | -$300.6K |
| DT | 2026-05-18 16:24 | 2026-05-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 204.1K | +4% | +$30.3K |
| DMT | 2026-05-18 16:24 | 2026-05-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $20.29 | -12.5K | 191.6K | -6% | -$253.6K |
| DT | 2026-04-28 19:49 | 2026-04-27 | BCAX | Raben David | Chief Medical Off | M - OptEx | $3.79 | +5,500 | 60.8K | +10% | +$20.8K |
| DT | 2026-04-28 19:49 | 2026-04-27 | BCAX | Raben David | Chief Medical Off | S - Sale+OE | $22.88 | -5,500 | 55.3K | -9% | -$125.8K |
| DT | 2026-04-22 16:53 | 2026-04-21 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +9,200 | 154.6K | +6% | +$34.9K |
| DT | 2026-04-22 16:53 | 2026-04-21 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $23.00 | -9,200 | 145.4K | -6% | -$211.6K |
| DMT | 2026-04-20 19:27 | 2026-04-16+ | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $4.24 | +37.8K | 377.2K | +11% | +$160.2K |
| DT | 2026-04-20 19:27 | 2026-04-20 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $23.61 | -15.0K | 362.2K | -4% | -$354.1K |
| DT | 2026-04-17 16:55 | 2026-04-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 208.6K | +4% | +$30.3K |
| DMT | 2026-04-17 16:55 | 2026-04-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $23.01 | -12.5K | 196.1K | -6% | -$287.6K |
| D | 2026-03-26 | 2026-03-25 | BCAX | Raben David | Chief Medical Off | S - Sale+OE | $18.95 | -5,500 | 55.3K | -9% | -$104.2K |
| D | 2026-03-26 | 2026-03-25 | BCAX | Raben David | Chief Medical Off | M - OptEx | $3.79 | +5,500 | 60.8K | +10% | +$20.8K |
| D | 2026-03-24 | 2026-03-23 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +9,200 | 154.6K | +6% | +$34.9K |
| D | 2026-03-24 | 2026-03-23 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.52 | -9,200 | 145.4K | -6% | -$170.4K |
| DM | 2026-03-20 | 2026-03-18+ | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $18.82 | -15.0K | 339.4K | -4% | -$282.4K |
| DM | 2026-03-20 | 2026-03-18+ | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +15.0K | 345.9K | +5% | +$56.9K |
| DM | 2026-03-17 | 2026-03-16 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $19.66 | -12.5K | 200.6K | -6% | -$245.8K |
| D | 2026-03-17 | 2026-03-16 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 213.1K | +4% | +$30.3K |
| D | 2026-03-11 | 2026-03-09 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $19.17 | -36.8K | 339.4K | -10% | -$704.8K |
| D | 2026-03-11 | 2026-03-09 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +36.8K | 376.2K | +11% | +$139.3K |
| DM | 2026-03-06 | 2026-03-04+ | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +8,234 | 341.2K | +2% | +$31.2K |
| DM | 2026-03-06 | 2026-03-04+ | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $18.74 | -8,234 | 339.4K | -2% | -$154.3K |
| DM | 2026-03-05 | 2026-03-03 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.16 | -17.4K | 205.1K | -8% | -$315.8K |
| D | 2026-03-05 | 2026-03-03 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +12.9K | 222.5K | +6% | +$48.9K |
| DM | 2026-03-05 | 2026-03-03+ | BCAX | Raben David | Chief Medical Off | S - Sale+OE | $18.52 | -16.5K | 55.3K | -23% | -$305.6K |
| DM | 2026-03-05 | 2026-03-03+ | BCAX | Raben David | Chief Medical Off | M - OptEx | $3.79 | +16.5K | 55.5K | +42% | +$62.5K |
| DM | 2026-03-05 | 2026-03-03+ | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.23 | -16.5K | 145.4K | -10% | -$301.0K |
| DM | 2026-03-05 | 2026-03-03+ | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +16.5K | 152.7K | +12% | +$62.6K |
| DI | 2026-03-02 | 2026-02-26 | BCAX | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $16.00 | +300.0K | 4.60M | +7% | +$4.80M |
| D | 2026-02-27 | 2026-02-25 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +3,108 | 213.3K | +1% | +$11.8K |
| DM | 2026-02-27 | 2026-02-25 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.04 | -3,631 | 209.6K | -2% | -$65.5K |
| D | 2026-01-26 | 2026-01-22 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +1,882 | 147.2K | +1% | +$7,133 |
| D | 2026-01-26 | 2026-01-22 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.15 | -1,882 | 145.4K | -1% | -$34.2K |
| 2026-01-26 | 2026-01-22 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale | $18.10 | -3,828 | 210.2K | -2% | -$69.3K | |
| 2026-01-20 | 2026-01-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale | $18.02 | -149 | 214.0K | -0.1% | -$2,685 | |
| D | 2025-12-29 | 2025-12-26 | BCAX | Raben David | Chief Medical Off | M - OptEx | $3.79 | +19.8K | 55.3K | +56% | +$75.0K |
| D | 2025-12-29 | 2025-12-26 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $4.44 | +25.0K | 214.1K | +13% | +$111.0K |
| D | 2025-12-23 | 2025-12-22 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +9,200 | 154.6K | +6% | +$34.9K |
| D | 2025-12-23 | 2025-12-22 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.31 | -9,200 | 145.4K | -6% | -$168.5K |
| D | 2025-12-18 | 2025-12-16 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $5.45 | +29.5K | 339.4K | +10% | +$160.8K |
| DM | 2025-12-16 | 2025-12-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.68 | -12.5K | 193.6K | -6% | -$233.5K |
| D | 2025-12-16 | 2025-12-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 201.6K | +4% | +$30.3K |
| D | 2025-11-25 | 2025-11-21 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 206.1K | +4% | +$30.3K |
| DM | 2025-11-25 | 2025-11-21 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.05 | -12.5K | 198.1K | -6% | -$225.6K |
| DM | 2025-11-25 | 2025-11-21+ | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +18.4K | 163.2K | +13% | +$69.7K |
| DM | 2025-11-25 | 2025-11-21+ | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.54 | -18.4K | 145.4K | -11% | -$341.1K |
| D | 2025-11-25 | 2025-11-24 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $18.86 | -41.2K | 309.9K | -12% | -$776.3K |
| D | 2025-11-25 | 2025-11-24 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +41.2K | 351.1K | +13% | +$156.0K |
| DM | 2025-11-25 | 2025-11-24+ | BCAX | Raben David | Chief Medical Off | M - OptEx | $3.79 | +11.0K | 40.1K | +38% | +$41.7K |
| DM | 2025-11-25 | 2025-11-24+ | BCAX | Raben David | Chief Medical Off | S - Sale+OE | $18.64 | -11.0K | 35.5K | -24% | -$205.1K |
| D | 2025-10-20 | 2025-10-16 | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $18.83 | -24.1K | 309.9K | -7% | -$453.9K |
| D | 2025-10-20 | 2025-10-16 | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +24.1K | 334.0K | +8% | +$91.4K |
| DM | 2025-10-16 | 2025-10-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.16 | -12.5K | 198.1K | -6% | -$227.0K |
| D | 2025-10-16 | 2025-10-15 | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +8,000 | 210.6K | +4% | +$30.3K |
| DM | 2025-10-15 | 2025-10-13+ | BCAX | Mazumdar Claire | CEO, Dir | S - Sale+OE | $18.88 | -24.7K | 309.9K | -7% | -$466.9K |
| DM | 2025-10-15 | 2025-10-13+ | BCAX | Mazumdar Claire | CEO, Dir | M - OptEx | $3.79 | +24.7K | 321.3K | +8% | +$93.7K |
| D | 2025-10-10 | 2025-10-09 | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +6,415 | 151.8K | +4% | +$24.3K |
| D | 2025-10-10 | 2025-10-09 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.23 | -6,415 | 145.4K | -4% | -$116.9K |
| D | 2025-10-10 | 2025-10-09 | BCAX | Raben David | Chief Medical Off | M - OptEx | $3.79 | +22.0K | 57.5K | +62% | +$83.4K |
| D | 2025-10-10 | 2025-10-09 | BCAX | Raben David | Chief Medical Off | S - Sale+OE | $18.45 | -22.0K | 35.5K | -38% | -$405.9K |
| DM | 2025-10-08 | 2025-10-06+ | BCAX | Cohlhepp Ryan | Pres, COO, Dir | S - Sale+OE | $18.06 | -50.5K | 221.1K | -19% | -$912.0K |
| DM | 2025-10-08 | 2025-10-06+ | BCAX | Cohlhepp Ryan | Pres, COO, Dir | M - OptEx | $3.79 | +32.0K | 245.1K | +15% | +$121.3K |
| DM | 2025-10-08 | 2025-10-06+ | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.21 | -30.4K | 145.4K | -17% | -$553.2K |
| DM | 2025-10-08 | 2025-10-06+ | BCAX | Hyep Ivan | CFO | M - OptEx | $3.79 | +30.4K | 151.9K | +25% | +$115.2K |
| D | 2025-10-01 | 2025-09-29 | BCAX | Meisner Lara | CLO | M - OptEx | $9.24 | +33.8K | 33.8K | New | +$312.4K |
| D | 2025-10-01 | 2025-09-29 | BCAX | Meisner Lara | CLO | S - Sale+OE | $14.75 | -33.8K | 0 | -100% | -$498.7K |
| D | 2025-09-17 | 2025-09-15 | BCAX | Meisner Lara | CLO | S - Sale+OE | $11.49 | -15.8K | 0 | -100% | -$181.9K |
| D | 2025-09-17 | 2025-09-15 | BCAX | Meisner Lara | CLO | M - OptEx | $5.45 | +15.8K | 15.8K | New | +$86.3K |
| D | 2025-06-18 | 2025-06-16 | BCAX | Meisner Lara | CLO | S - Sale+OE | $10.43 | -15.8K | 0 | -100% | -$165.1K |
| D | 2025-06-18 | 2025-06-16 | BCAX | Meisner Lara | CLO | M - OptEx | $5.45 | +15.8K | 15.8K | New | +$86.3K |
| DMT | 2025-03-18 | 2025-03-14 | BCAX | Meisner Lara | CLO | S - Sale+OE | $12.90 | -79.1K | 30.6K | -72% | -$1.02M |
| DT | 2025-03-18 | 2025-03-14 | BCAX | Meisner Lara | CLO | M - OptEx | $5.45 | +79.1K | 79.1K | New | +$431.3K |
| DMI | 2024-09-18 | 2024-09-16 | BCAX | RA Capital Nexus Fund III, L.P. | Dir | C - Cnv Deriv | — | +5.12M | 2.62M | New | — |
| DMI | 2024-09-18 | 2024-09-16 | BCAX | RA Capital Nexus Fund III, L.P. | Dir | P - Purchase | $18.00 | +1.83M | 2.65M | +224% | +$32.99M |
| DMI | 2024-09-18 | 2024-09-16 | BCAX | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | +1.01M | 54.1K | New | — |
| DI | 2024-09-18 | 2024-09-16 | BCAX | BONDERMAN DAVID | Former 10% Owner | C - Cnv Deriv | — | +1.96M | 1.96M | New | — |
| DMI | 2024-09-18 | 2024-09-16 | BCAX | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +1.12M | 1.12M | New | — |
| DMI | 2024-09-17 | 2024-09-17 | BCAX | Deerfield Private Design Fund V, L.P. | 10%, Possible Members of 10% Group | C - Cnv Deriv | — | +1.73M | 862.6K | New | — |
| DMI | 2024-09-17 | 2024-09-17 | BCAX | Deerfield Private Design Fund V, L.P. | 10%, Possible Members of 10% Group | P - Purchase | $18.00 | +70.0K | 897.6K | +8% | +$1.26M |
| DMI | 2024-09-16 | 2024-09-16 | BCAX | Biocon Ltd | 10% | C - Cnv Deriv | $0.00 | +5.41M | 4.44M | New | $0 |
| DMI | 2024-09-16 | 2024-09-16 | BCAX | Mazumdar-Shaw Kiran | Dir, 10% | C - Cnv Deriv | $0.00 | +6.17M | 324.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations